Target Gene Table
VIS IDVirusEnsembl IDGene TypeTarget GeneOncogeneTumor Suppressor GeneNCBI IDUniprot ID
TVIS10005763HBVENSG00000198626.19protein_codingRYR2NoNo6262Q92736
TVIS10014078HBVENSG00000198626.19protein_codingRYR2NoNo6262Q92736
TVIS10035770HBVENSG00000198626.19protein_codingRYR2NoNo6262Q92736
TVIS10039768HBVENSG00000198626.19protein_codingRYR2NoNo6262Q92736
TVIS10032474HBVENSG00000198626.19protein_codingRYR2NoNo6262Q92736
TVIS10040109HBVENSG00000198626.19protein_codingRYR2NoNo6262Q92736
TVIS10040586HBVENSG00000198626.19protein_codingRYR2NoNo6262Q92736
TVIS10040784HBVENSG00000198626.19protein_codingRYR2NoNo6262Q92736
TVIS30087644HIVENSG00000198626.19protein_codingRYR2NoNo6262Q92736
TVIS30080286HIVENSG00000198626.19protein_codingRYR2NoNo6262Q92736
TCGA Plot Options
Drug Information
GeneRYR2
DrugBank IDDB01195
Drug NameFlecainide
Target IDBE0005295
UniProt IDQ92736
Regulation Typeinhibitor
PubMed IDs25274603
CitationsMehra D, Imtiaz MS, van Helden DF, Knollmann BC, Laver DR: Multiple modes of ryanodine receptor 2 inhibition by flecainide. Mol Pharmacol. 2014 Dec;86(6):696-706. doi: 10.1124/mol.114.094623. Epub 2014 Oct 1.
GroupsApproved; Withdrawn
Direct ClassificationBenzamides
SMILESFC(F)(F)COC1=CC(C(=O)NCC2CCCCN2)=C(OCC(F)(F)F)C=C1
PathwaysFlecainide Action Pathway
PharmGKBPA449646
ChEMBLCHEMBL652